Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction Aurora Andrade; Sara Gonçalves; Ana Batista; Ana Teresa Timóteo; Ana Oliveira Soares; Fátima Franco; Otília Simões; Marisa Pardal; Mário Almeida; Margarida Lopes; Filipa Bernardo; José Silva Cardoso;

Dapagliflozin alleviates isoprenaline-induced cardiac hypertrophy by promoting mitophagy via AMPK¿2 signaling pathway Yue Feng; Zixiong Zhu; Xin Jing; Yibo Zhang; Yubin He; Xuewen Li;

Quality of life score association with other patient-reported outcomes: Validating Minnesota Living with Heart Failure Questionnaire to Portuguese Irene Marques; Sofia Viamonte; Milton Severo; António Gomes Pinto; Cândida Fonseca; Henrique Cyrne Carvalho;